Mural Oncology (MURA)
NASDAQ: MURA
· Real-Time Price · USD
2.44
-0.01 (-0.41%)
At close: Jun 17, 2025, 2:22 PM
-0.41% (1D)
| Bid | 2.44 |
| Market Cap | 42.14M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -130.73M |
| EPS (ttm) | -7.67 |
| PE Ratio (ttm) | -0.32 |
| Forward PE | -1.11 |
| Analyst | Buy |
| Ask | 2.46 |
| Volume | 76,506 |
| Avg. Volume (20D) | 4,709,473 |
| Open | 2.44 |
| Previous Close | 2.45 |
| Day's Range | 2.44 - 2.47 |
| 52-Week Range | 0.95 - 4.74 |
| Beta | 3.40 |
About MURA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MURA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for MURA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+133.98%
Mural Oncology shares are trading higher after the...
Unlock content with
Pro Subscription
2 months ago
-61.62%
Mural Oncology shares are trading lower after the company announced it will discontinue its final analysis of Nemvaleukin in combination with KEYTRUDA and will cease further development. Jones Trading downgraded the stock from Buy to Hold.
